Molecular Partners AG (MOLN)
4.37
+0.06
(+1.49%)
USD |
NASDAQ |
Dec 10, 16:00
4.37
0.00 (0.00%)
After-Hours: 20:00
Molecular Partners Enterprise Value: 31.60M for Dec. 9, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| BeOne Medicines Ltd. | 33.08B |
| AC Immune SA | 125.06M |
| CRISPR Therapeutics AG | 3.728B |
| Addex Therapeutics Ltd. | 6.635M |
| NewCelX Ltd. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.79M |
| Total Expenses (Quarterly) | 14.79M |
| EPS Diluted (Quarterly) | -0.3955 |
| Earnings Yield | -43.69% |
| Normalized Earnings Yield | -42.27 |